DEUS EX MACHINA

What DEUS EX MACHINA does

DEUS EX MACHINA (legal entity: DEUS EX MACHINA IKE) is a privately held Greek AI/bioinformatics company founded in March 2017 by Dr. Ilias Tagkopoulos, a Princeton-trained computer scientist and UC Davis professor who directs the USDA/NSF AI Institute for Next-Generation Food Systems. The company operates from dual offices in Athens (founding) and Thessaloniki (opened September 2017) and employs 54+ scientists, engineers, and data specialists spanning Data Science, Multiphysics, Material and Sensory Science, Software Engineering, Chemoinformatics, and Bioinformatics. It targets R&D teams in the life sciences, health, nutrition, and food manufacturing sectors, helping them accelerate scientific discovery and convert data into actionable predictions through proprietary AI platforms and applied ML services.

The company's core product is the Ingredient Upscaling Platform — an AI-powered SaaS solution that combines molecular bioinformatics, sensory science, and multi-physics modeling to help food and ingredient manufacturers transform production by-products (e.g., cereal waste, apple pulp, whey, eggshell residues) into high-value, health-promoting ingredients. Supporting offerings include the LEAP scientific discovery platform (delivered in partnership with US-based PIPA LLC, a co-founded company), HPC-based process optimization using mathematical optimization and graph theory, the HAL9000 cloud AI service for drug/chemical compound discovery and predictive analytics, and bespoke professional application development. Underlying AI capabilities span NLP, predictive analytics, knowledge retrieval, optimization, and generative association modeling. The platform was awarded €2 million in EU 'Ellada 2.0' grant funding in March 2025, with broad market release targeted for Q3 2026 following a structured beta program with select CPG and ingredient innovation partners.

Revenue is generated through monthly or annual SaaS subscriptions to its cloud AI platform, managed services, and bespoke technical/consulting engagements. Pricing is not publicly disclosed and is likely quote-based for enterprise clients. The customer mix spans food and ingredient manufacturers (primary), life sciences and health companies (primary), and consumer health/petcare (secondary). A notable enterprise validation is the multi-year agreement with Mars, Inc. (April 2022, via PIPA) to use LEAP for plant-based ingredient discovery. The company has grown primarily on EU non-dilutive grant funding rather than institutional venture capital, with founder Ilias Tagkopoulos holding 99% ownership.

Name

DEUS EX MACHINA

Legal name

DEUS EX MACHINA IKE

Website

https://ekmechanes.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

DEUS EX MACHINA is a Greek AI/bioinformatics company that builds AI platforms — notably the Ingredient Upscaling Platform and LEAP — to help life sciences, health, nutrition, and food manufacturers accelerate scientific discovery and convert production by-products into high-value functional ingredients.

Ownership category

akta.pro rank

Product category

AI Bioinformatics Software

NAICS

Food Product Machinery Manufacturing (333241)

SIC

Electronic Components & Accessories (3670)

akta.pro primary industry

AI Integration & Orchestration Platforms (Connectors, Workflow, iPaaS for AI) (HDAEANAI)

akta.pro secondary industries

End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management) (HDAEANAA), AI/ML Engineering & Model Development Services (BPAEAHAF)

Keywords

• AI bioinformatics platform
• Food ingredient AI
• Nutrition analytics software
• Scientific discovery AI
• Food waste valorization

Headquarters

HQ city

Thessaloníki

HQ country

Greece

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. SaaS Platform Subscription: Cloud computing DEUS EX MACHINA AI platform offered on monthly subscription or annual license basis. Provides access to AI-powered tools for drug discovery, chemical compound discovery, scientific research, product research and placement, as well as prescriptive and predictive analytics.
2. Managed Services: Managed service offerings alongside the SaaS platform for ongoing support and platform management.
3. Technical Consultation: Technical and technology consultation services in the field of artificial intelligence, working with clients on process optimization and custom analytics solutions.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

DEUS EX MACHINA develops and delivers AI-powered software solutions for the food, nutrition, and health industries. Its core product is the Ingredient Upscaling Platform, a SaaS solution that uses AI, molecular bioinformatics, and sensory science to help food and ingredient manufacturers transform production by-products into high-value, health-promoting ingredients. The company also offers supporting AI services including process optimization, scalable machine learning, AI cloud services (HAL9000), and custom professional applications.

Product overview

DEUS EX MACHINA is a boutique bioinformatics software company offering AI-powered solutions for the food, nutrition, and health industries. The core product is the Ingredient Upscaling Platform, a SaaS solution that transforms food industry by-products into high-value ingredients using AI, molecular bioinformatics, and sensory science. Supporting services include Process Optimization (using mathematical optimization, ML, graph theory, and HPC simulation), Scalable Machine Learning (advanced analytics with bioinformatics, ML, and NLP), AI Services (cloud-based AI for drug discovery and predictive analytics), and Professional Applications (custom software development for data analytics solutions).

Differentiator

Problem solved

Functional benefit

Products and services

• Ingredient Upscaling Platform AI-powered SaaS platform that helps food and ingredient manufacturers transform production by-products into high-value, health-promoting ingredients using advanced AI, molecular bioinformatics, and sensory science. It supports ingredient profiling, food formulation optimization, evidence discovery, and collaborative project workflows.
• Process Optimization Evidence-based process optimization service using mathematical optimization, machine learning, graph theory, and multi-scale modeling and simulation on HPC systems to solve manufacturing challenges including experimental design, product matching, and active learning systems.
• Scalable Machine Learning Advanced analytics service that transforms datasets into actionable insights using bioinformatics, machine learning, and natural language processing. Past projects include financial data analysis, disease onset prediction, and customer satisfaction analysis.
• AI Services (HAL9000) Cloud-based software-as-a-service delivering AI capabilities for drug discovery, chemical compound discovery, scientific research, product research and placement, and prescriptive and predictive analytics, accessed via monthly subscription or annual license.
• Professional Applications Custom desktop and smartphone application development services to house data analytics solutions, including mobile apps, clinical decision support applications, and database management web services.

Quantifiable outcome

• AI platform expected to help address the global food waste crisis with approximately 2.5 billion tons of food wasted annually and at least 30% lost during production processes
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature4 records

Partnerships

Two partnerships are on record, tiered major and core.

• Mars, Inc.majorStrategic or Co-development Partner · 26 April 2022PIPA LLC, DEUS EX MACHINA's business partner, signed a multi-year agreement with Mars, Inc. to accelerate the discovery of new plant-based ingredients through the LEAP AI platform. The agreement aims to support the discovery of molecules that could lead to the development of new conventional and functional products. DEUS EX MACHINA celebrates this partnership as it aligns with their shared mission to use AI for innovation in Health and Nutrition.
• PIPA LLCcoreStrategic or Co-development Partner · 1 January 2017PIPA LLC is a Machine Learning company based in California, USA with strong ties to DEUS EX MACHINA. The companies have collaborated on impactful projects on Health, Nutrition, and Life Sciences for five years. PIPA is co-founded by Dr. Ilias Tagkopoulos, who is also the founder of DEUS EX MACHINA. Through this partnership, DEUS has collaborated on projects leveraging AI platforms like LEAP for scientific discovery.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Market position

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/DeusExMachinaAI
• Facebookfacebook.com/DeusExMachinaAI
• LinkedInlinkedin.com/company/deus-ex-machina-ai

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DEUS EX MACHINA